INS and Hypoglycemia: As insulin glargine provides a more prolonged, consistent duration of action and a lower risk of hypoglycaemia compared to NPH (humane isophane) insulin [3, 4, 17], glycaemic control improves while having a scarce effect on hypoglycaemia rates.